| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |